Concurrent Afatinib and Whole-Brain Radiotherapy in Exon 19-del-EGFR Mutant Lung Adenocarcinoma: A Case Report and Mini Review of the Literature

Management of leptomeningeal metastases: Prognostic factors and associated outcomes

(2016) Jeffrey V. Brower et al.   JOURNAL OF CLINICAL NEUROSCIENCE

Whole brain radiotherapy in management of non-small-cell lung carcinoma associated leptomeningeal carcinomatosis: evaluation of prognostic factors

(2016) Yurday Ozdemir et al.   JOURNAL OF NEURO-ONCOLOGY

Leptomeningeal Metastases in Patients with NSCLC with EGFR Mutations

(2016) Yang-Si Li et al.   Journal of Thoracic Oncology

EGFR TKIs plus WBRT Demonstrated No Survival Benefit Other Than That of TKIs Alone in Patients with NSCLC and EGFR Mutation and Brain Metastases

(2016) Tao Jiang et al.   Journal of Thoracic Oncology

First-Line Afatinib versus Chemotherapy in Patients with Non–Small Cell Lung Cancer and Common Epidermal Growth Factor Receptor Gene Mutations and Brain Metastases

(2016) Martin Schuler et al.   Journal of Thoracic Oncology

Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors for Non–Small-Cell Lung Cancer Patients with Leptomeningeal Carcinomatosis

(2015) Bin-Chi Liao et al.   Journal of Thoracic Oncology

Efficacy of the Irreversible ErbB Family Blocker Afatinib in Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor (TKI)–Pretreated Non–Small-Cell Lung Cancer Patients with Brain Metastases or Leptomeningeal Disease

(2015) Petra Hoffknecht et al.   Journal of Thoracic Oncology

Afatinib versus cisplatin-based chemotherapy for EGFR mutation-positive lung adenocarcinoma (LUX-Lung 3 and LUX-Lung 6): analysis of overall survival data from two randomised, phase 3 trials

(2015) James Chih-Hsin Yang et al.   LANCET ONCOLOGY

Afatinib in Treatment-Naive Patients With EGFR-Mutated Lung Adenocarcinoma With Brain Metastasis

(2015) Shih-Hong Li et al.   MEDICINE

EGFR tyrosine kinase inhibitors versus cranial radiation therapy for EGFR mutant non-small cell lung cancer with brain metastases: A systematic review and meta-analysis

(2015) Yu Yang Soon et al.   RADIOTHERAPY AND ONCOLOGY

Blood-brain barrier permeability of gefitinib in patients with brain metastases from non-small-cell lung cancer before and during whole brain radiation therapy

(2015) Yin-duo Zeng et al.   Oncotarget

Afatinib with Concurrent Radiotherapy in a Patient with Metastatic Non-Small Cell Lung Cancer

(2014) Akin Atmaca et al.   Oncology Research and Treatment

Leptomeningeal Carcinomatosis in Non–Small-Cell Lung Cancer Patients: Impact on Survival and Correlated Prognostic Factors

(2013) Su Jin Lee et al.   Journal of Thoracic Oncology

Cerebrospinal Fluid Concentrations of Gefitinib in Patients With Lung Adenocarcinoma

(2012) Jing Zhao et al.   Clinical Lung Cancer

Leptomeningeal Metastasis from Non-small Cell Lung Cancer: Survival and the Impact of Whole Brain Radiotherapy

(2011) Patrick G. Morris et al.   Journal of Thoracic Oncology

New Strategies in the Management of Leptomeningeal Metastases

(2010) Morris D. Groves   ARCHIVES OF NEUROLOGY

Leptomeningeal metastasis

(2010) Marc C Chamberlain   CURRENT OPINION IN ONCOLOGY